Robert Yahn Overview
- Investor Type
-
Angel
- Investments
-
3
- Portfolio
-
3
Robert Yahn General Information
Description
Mr. Robert Yahn serves as Chief Executive Officer, Chief Operating Officer and Board member at Gander Technologies. He is an Angel Investor.
Business Details
Primary Investor Type
Corporate Office
- 2145 South Clermont Street
- Unit 1
- Denver, CO 80222
- United States
Robert Yahn Investments (3)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| VetDC | 30-Sep-2016 | Later Stage VC | Drug Discovery | Generating Revenue | ||
| MenoGeniX | 27-May-2013 | Biotechnology | Clinical Trials - Phase 2 | |||
| Verblio | 15-Oct-2012 | Media and Information Services (B2B) | Profitable |
Robert Yahn Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Robert Yahn FAQs
-
Who is Robert Yahn?
Robert Yahn is an angel Investor who has made 3 investments.
-
What kind of investor is Robert Yahn?
Robert Yahn is an angel investor.
-
What does Robert Yahn do?
As an angel investor, Robert Yahn invests personal money into promising companies, typically in exchange for equity.
-
What has Robert Yahn invested in?
Robert Yahn has made numerous investments in companies like VetDC, MenoGeniX, and Verblio within the Drug Discovery, Biotechnology, and Media and Information Services (B2B) industries.
-
What has Robert Yahn invested in recently?
Robert Yahn's latest investment was on 30-Sep-2016 in VetDC, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
